Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease

Huan Wang(Chengdu Military General Hospital), Guangyong Sun(Capital Medical University), Aiting Yang(Beijing Chao-Yang Hospital, Capital Medical University), Dong Zhao(Peking University), Song Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dong Zhang(Capital Medical University), Mengyi Li(Capital Medical University), Zhongtao Zhang(Capital Medical University), Songlin Wang(Sun Yat-sen University), Yushang Zhao(Capital Medical University), Changying Li(Capital Medical University), Yanbing Zhu(Capital Medical University), Yuhualei Pan(Second Affiliated Hospital of Guangzhou Medical University)
JHEP Reports
March 9, 2023
10.1016/j.jhepr.2023.100726
Cited by 16

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Effect of outdoor activity on myopia onset and progression in school-aged children in northeast china: the sujiatun eye care study
|BMC Ophthalmology|2015|298
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
Cortical and subcortical gray matter shrinkage in alcohol-use disorders: a voxel-based meta-analysis
|Neuroscience & Biobehavioral Reviews|2016|258
Understanding consumers’ behavior to adopt self-service parcel services for last-mile delivery
|Journal of Retailing and Consumer Services|2019|198